Patents by Inventor Jan Pravsgaard Christensen

Jan Pravsgaard Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRIMING OF AN IMMUNE RESPONSE
    Publication number: 20210386842
    Abstract: The present invention relates to a technology and method of priming of an immune response using invariant chain linked antigen, when these are used to prime a subsequent booster immunization using any suitable vacci.
    Type: Application
    Filed: June 17, 2021
    Publication date: December 16, 2021
    Applicant: UNIVERSITY OF COPENHAGEN
    Inventors: Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen, Mirjana Grujic
  • NUCLEOTIDE VACCINE
    Publication number: 20210230633
    Abstract: The present invention relates to a vaccine comprising a nucleic acid construct such as a DNA construct especially a nucleic acid construct comprising sequences encoding invariant chain operatively linked to antigenic protein or peptide encoding sequences. The vaccine stimulates an immune response, especially an immune response in an MHC-I dependent, but CD4+ T-cell independent manner.
    Type: Application
    Filed: February 3, 2021
    Publication date: July 29, 2021
    Applicant: Copenhagen University
    Inventors: Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen
  • PRIMING OF AN IMMUNE RESPONSE
    Publication number: 20170290898
    Abstract: The present invention relates to a technology and method of priming of an immune response using invariant chain linked antigen, when these are used to prime a subsequent booster immunization using any suitable vacci.
    Type: Application
    Filed: April 25, 2017
    Publication date: October 12, 2017
    Applicant: University of Copenhagen
    Inventors: Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen, Mirjana Grujic
  • NUCLEOTIDE VACCINE
    Publication number: 20150368672
    Abstract: The present invention relates to a vaccine comprising a nucleic acid construct such as a DNA construct especially a nucleic acid construct comprising sequences encoding invariant chain operatively linked to antigenic protein or peptide encoding sequences. The vaccine stimulates an immune response, especially an immune response in an MHC-I dependent, but CD4+ T-cell independent manner.
    Type: Application
    Filed: August 4, 2015
    Publication date: December 24, 2015
    Applicant: Copenhagen University
    Inventors: Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen
  • PRIMING OF AN IMMUNE RESPONSE
    Publication number: 20150056227
    Abstract: The present invention relates to a technology and method of priming of an immune response using invariant chain linked antigen, when these are used to prime a subsequent booster immunization using any suitable vacci.
    Type: Application
    Filed: September 10, 2014
    Publication date: February 26, 2015
    Applicant: University of Copenhagen
    Inventors: Peter Johannes Holst, Allen Randrup Thomsen, Jan Pravsgaard Christensen, Mirjana Grujic
  • PRIMING OF AN IMMUNE RESPONSE
    Publication number: 20110293704
    Abstract: The present invention relates to a technology and method of priming of an immune response using invariant chain linked antigen, when these are used to prime a subsequent booster immunization using any suitable vacci.
    Type: Application
    Filed: November 20, 2009
    Publication date: December 1, 2011
    Applicant: University of Copenhagen
    Inventors: Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen, Mirjana Grujic
  • NUCLEOTIDE VACCINE
    Publication number: 20100278904
    Abstract: The present invention relates to a vaccine comprising a nucleic acid construct such as a DNA construct especially a nucleic acid construct comprising sequences encoding invariant chain operatively linked to antigenic protein or peptide encoding sequences. The vaccine stimulates an immune response, especially an immune response in an MHC-I dependent, but CD4+ T-cell independent manner.
    Type: Application
    Filed: November 30, 2006
    Publication date: November 4, 2010
    Applicant: Copenhagen University
    Inventors: Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen